; (B) provide a period for public comment on such proposed guidance; and (C) not later than 1 year after the end of such public comment period, finalize such guidance. (2) Contents The guidance under paragraph (1) shall address— (A) the process by which a person may request qualification under section 507A of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a); (B) the eligibility criteria under subsection (b) of such section 507A; (C) the information that a person requesting such qualification is required to submit under subsection (c) of such section 507A; and (D) how the Secretary intends to evaluate requests under such section 507A. 3. Regulations on nonclinical testing methods (a) In general Not later than 90 days after the date of enactment of this Act, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall initiate a rulemaking under section 553 of title 5, United States Code, to implement section 505(z) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(z) ). (b) Technical amendment Section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) is amended by designating the second subsection (z) (relating to clinical trial diversity action plans), as added by section 3601(a) of the Health Extenders, Improving Access to Medicare, Medicaid, and CHIP, and Strengthening Public Health Act of 2022 (division FF of Public Law 117–328 ), as subsection (aa).